Lassen Emerges with over $31M and a mAb for Fibrosis and Cancer

June 18, 2020

Lassen Therapeutics Raises $31 Million to Pursue IL-11 Antibody for Cancer and Fibrosis

June 18, 2020

Lassen Launches to Advance Antibodies Against Fibrosis, Cancer

June 18, 2020

Lassen Therapeutics Uncloaks with $31M and Anti-IL-11 Antibody

June 17, 2020

All In on IL-11, Lassen Unveils with Dual Focus on Fibrosis and Cancer

June 17, 2020

Lassen Therapeutics Launches to Discover and Develop Novel Antibody Therapeutics Including Lead Program Targeting IL-11 to Treat Fibrosis and Oncology

June 17, 2020